KFI
ABBV icon

Key Financial Inc’s AbbVie ABBV Stock Holding History

Key Financial Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.6M Buy
16,553
+533
+3% +$118K 0.64% 34
2025
Q4 		$3.66M Buy
16,020
+158
+1% +$36K 0.67% 32
2025
Q3 		$3.88M Sell
15,862
-138
-0.9% -$28.1K 0.72% 33
2025
Q2 		$2.97M Sell
16,000
-27
-0.2% -$5.02K 0.6% 35
2025
Q1 		$3.36M Buy
16,027
+412
+3% +$80.1K 0.73% 29
2024
Q4 		$2.77M Buy
15,615
+315
+2% +$57.9K 0.63% 33
2024
Q3 		$3.02M Buy
15,300
+31
+0.2% +$5.79K 0.67% 30
2024
Q2 		$2.62M Buy
15,269
+154
+1% +$25.5K 0.63% 33
2024
Q1 		$2.75M Buy
15,115
+324
+2% +$55.8K 0.7% 31
2023
Q4 		$2.29M Buy
14,791
+15
+0.1% +$2.19K 0.63% 34
2023
Q3 		$2.2M Buy
14,776
+13
+0.1% +$1.91K 0.74% 29
2023
Q2 		$1.99M Buy
14,763
+638
+5% +$93.6K 0.66% 31
2023
Q1 		$2.25M Buy
14,125
+2,194
+18% +$335K 0.82% 27
2022
Q4 		$1.6M Hold
11,931
– – 0.76% 28
2022
Q3 		$1.6M Buy
11,931
+5,447
+84% +$782K 0.75% 28
2022
Q2 		$997K Buy
6,484
+76
+1% +$11.6K 0.54% 35
2022
Q1 		$1.04M Buy
6,408
+421
+7% +$61.2K 0.52% 32
2021
Q4 		$811K Buy
5,987
+11
+0.2% +$1.3K 0.41% 47
2021
Q3 		$645K Hold
5,976
– – 0.37% 56
2021
Q2 		$695K Buy
5,976
+111
+2% +$12.5K 0.39% 52
2021
Q1 		$635K Buy
5,865
+160
+3% +$17.1K 0.42% 47
2020
Q4 		$611K Sell
5,705
-100
-2% -$9.61K 0.45% 45
2020
Q3 		$508K Buy
5,805
+100
+2% +$9.41K 0.52% 48
2020
Q2 		$550K Buy
5,705
+256
+5% +$22.5K 0.63% 40
2020
Q1 		$410K Sell
5,449
-450
-8% -$38.3K 0.42% 48
2019
Q4 		$522K Buy
+5,899
New +$490K 0.49% 50

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Key Financial Inc's ABBV Position: Q1 2026 in Review

Key Financial Inc increased its AbbVie (ABBV) stake by 3.3% in Q1 2026, buying an estimated $118K and bringing the position to 16,553 shares worth $3.6M. The position accounts for 0.64% of the portfolio, ranked #34.

Key Financial Inc first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.88M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Key Financial Inc held 16,553 shares of AbbVie worth $3.6M as of Q1 2026.
  • Key Financial Inc bought 533 AbbVie shares in Q1 2026, an estimated $118K.
  • AbbVie made up 0.64% of Key Financial Inc's portfolio in Q1 2026, its #34 holding.
  • Key Financial Inc first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • Key Financial Inc's AbbVie position peaked at $3.88M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Key Financial Inc's 13F filing for Q1 2026, filed 24 Apr 2026.